Why the study?
When large Fontan circuit fenestrations cause profound hypoxia and effort intolerance, techniques to reduce their size are lacking.
Does off-label use of atrial flow regulators improve oxygenation in patients with large undesirable fenestrations following extracardiac conduit Fontan surgeries?
Does off-label use of atrial flow regulators improve oxygenation in patients with large undesirable fenestrations following extracardiac conduit Fontan surgeries?
Off-label use of atrial flow regulators may be a viable transcatheter technique to reduce the size of large undesirable fenestrations and improve oxygenation following extracardiac conduit Fontan surgeries.
Answers are grounded in this paper and cite their sources.
May support transcatheter fenestration reduction in Fontan patients; hypothesis-generating and requires prospective validation.
Fontan surgery streamlines the systemic venous return through the pulmonary circulation before filling the systemic ventricle in univentricular hearts. The venous congestion leads to effusions, lowers cardiac output, and affects organ perfusion. Fenestrations in the Fontan circuit improve forward flow through the ventricles, lower venous pressures, and reduce perioperative morbidity. When large fenestrations cause profound hypoxia and effort intolerance, there are no current techniques to reduce their size. Atrial flow regulators with a predetermined orifice were used off-label in three borderline patients with large undesirable fenestrations following extracardiac conduit Fontan surgeries. This resulted in improved oxygenation without marked elevation of venous pressures, while retaining the patency of the decompressive fenestration.
No takes yet. Share an insight, caveat, or question.
Sivakumar et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: